Lunai Bioworks Inc.
LNAI | NASDAQ
$2.23
-$0.07 (-3.04%)
At close: Sep 22, 2026, 4:00 PM ET
$2.21
-$0.02 (-0.69%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Company Profile
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Key Executives
| Name | Position |
|---|---|
| David H. Weinstein | Chief Executive Officer & Director |
| Nathen Fuentes | Chief Financial Officer |
Lunai Bioworks Inc.
| Country | United States |
| IPO Date | Sep 29, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 29 |
| CEO | David H. Weinstein |
Contact Details
2080 Century Park East Los Angeles,
California 90067 United States
Stock Details
| Ticker Symbol | LNAI |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001527728 |
| CUSIP Number | 29350E302 |
| ISIN Number | US29350E3027 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove LNAI